0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

The Lyme Disease Vaccine: Conception, Development, and Implementation

Wendy Todaro Thanassi, MA, MD; and Robert T. Schoen, MD
[+] Article and Author Information

From Yale University School of Medicine, New Haven, Connecticut.


Requests for Single Reprints: Wendy Todaro Thanassi, MD, Section of Emergency Medicine, Yale University School of Medicine, 464 Congress Avenue, New Haven, CT 06519.

Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints@mail.acponline.org.

Current Author Addresses: Dr. Thanassi: Section of Emergency Medicine, Yale University School of Medicine, 464 Congress Avenue, New Haven, CT 06519.

Dr. Schoen: Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, 60 Temple Street, Suite 6A, New Haven, CT 06510.


Ann Intern Med. 2000;132(8):661-668. doi:10.7326/0003-4819-132-8-200004180-00009
Text Size: A A A

In the past 20 years, remarkable strides have been made toward understanding and preventing Lyme disease in humans. In December 1998, the U.S. Food and Drug Administration approved a recombinant outer surface protein A vaccine against Lyme disease (LYMErix, SmithKline Beecham, Philadelphia, Pennsylvania). The vaccine, which is derived from a lipidated outer surface protein of the causative spirochete Borrelia burgdorferi, is important because it may decrease the morbidity and financial costs associated with Lyme disease. Its mechanism is unique because it works inside the tick vector itself, preventing the human from becoming infected.

Figures

Grahic Jump Location
Figure 1.
Number of reported cases of Lyme disease in the United States, 1982-1997.

Adapted from the Centers for Disease Control and Prevention.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Levels of antibody to the protective epitope of outer surface protein A (LA-2-equivalent antibody in vaccine recipients) over time.(63)

Arrows indicate month of primary immunization given. Error bars represent 95% CIs. Adapted with permission from Steere et al. .

Grahic Jump Location
Grahic Jump Location
Figure 3.
Reverse cumulative curve of LA-2-equivalent antibody levels at month 2.(63)

Dashed-and-dotted lines indicate 20 vaccinated persons with breakthrough cases of definite Lyme disease; dashed lines indicate 512 vaccinated persons in whom Lyme disease was not confirmed at year 1; solid lines indicate 395 vaccinated controls. Adapted with permission from Steere et al. .

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)